Group 1: Financial Performance - The company achieved a net profit of 2.029 billion yuan in 2024 and 413 million yuan in Q1 2025 [2] - The company is focused on improving production efficiency and quality to better return value to shareholders [2] Group 2: Market Conditions and Challenges - The company is closely monitoring raw material prices and market demand, adjusting production and procurement strategies accordingly [1] - There are concerns regarding the company's stock performance, with significant declines compared to the chemical sector and overall market trends [1][3] Group 3: Product and Technology - Key products include polycarbonate, formic acid, polyols, DMF, nylon 6, and DMC, with market prices subject to fluctuations [2] - The company has launched a 400,000-ton organic silicon project, with market price changes impacting profitability [2] Group 4: Corporate Governance and Investor Relations - The company has established a market value management system as of February 13, 2025 [2] - The company emphasizes transparent communication with investors and adherence to legal regulations regarding information disclosure [3]

特此公告。 鲁西化工集团股份有限公司 董事会 证券代码：000830 证券简称：鲁西化工 公告编号：2025-034 鲁西化工集团股份有限公司 网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，鲁西化工集团股份有限公司 （以下简称"公司"）将参加由山东证监局、山东上市公司协会与深圳 市全景网络有限公司联合举办的"2025年山东辖区上市公司投资者网上 集体接待日活动"，现将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演" 网站（http://rs.p5w.net）；或关注微信公众号（名称：全景财经）； 或下载全景路演APP,参与本次互动交流。活动时间为2025年5月15日（周 四）15:00-16:30。届时公司董事、总经理王延吉，财务总监毛江强， 董事会秘书刘月刚将在线就公司2024年度及2025年一季度经营业绩、公 司治理、发展战略、经营状况、融资计划、股权激励和可持续发展等投 资者关心的问题，与投资者进行沟通与交流，欢迎广大投资者踊跃参与！ 二〇二五年五月十二日 关于参加 ...

Investment Rating - The report maintains an "Overweight" rating for the basic chemicals and oil and gas sectors [4]. Core Viewpoints - The overall price spread in the industry improved in April 2025, with downstream sectors expected to recover first due to cost reduction and demand improvement [1][8]. - The April PMI data indicates a slight contraction in the chemical raw materials and products industry, suggesting ongoing supply-demand mismatches [1][11]. - The report anticipates a recovery starting in the second half of 2025, driven by improved domestic demand and exports to Asia, Africa, and Latin America [1][11]. Summary by Sections Supply and Demand Dynamics - The price spread for downstream chemical products improved in April due to supply constraints and seasonal demand replenishment, while midstream products still await recovery [2][8]. - The April PMI data was reported at 49, indicating a contraction in the chemical sector, but a recovery is expected as domestic economic conditions improve [11][24]. Investment Strategy - The report suggests that the second half of 2025 may mark the beginning of an upward trend, with a focus on resilient internal and external demand and improved competitive landscapes [3][32]. - Recommended stocks include China Petroleum, Hengli Petrochemical, and Juhua Co., with a focus on companies with strong dividend yields and cost reduction capabilities [6][32]. Key Recommendations - The report highlights specific companies for investment based on their competitive positioning and potential for recovery, including: - China Petroleum (601857 CH) with a target price of 9.79 and an "Overweight" rating [6]. - Hengli Petrochemical (600346 CH) with a target price of 17.55 and an "Overweight" rating [6]. - Juhua Co. (600160 CH) with a target price of 31.92 and a "Buy" rating [6]. - Other recommended companies include Dongyue Group, Luxi Chemical, Meihua Biological Technology, and Xinghuo Technology [6][32].

Core Viewpoint - The company's capacity construction is steadily advancing, and refined management along with energy-saving measures are continuously enhancing, indicating resilience in the company's performance [1] Investment Highlights - The rating is maintained at "Buy". Due to external environmental impacts on the prices of some chemical products, the EPS for 2025-2026 is revised down to 0.97/1.31 yuan (previously 1.19/1.4 yuan), with a new EPS for 2027 set at 1.36 yuan. Based on comparable company valuations and considering the company's growth potential, a 13x PE valuation for 2025 is given, corresponding to a target price of 12.61 yuan [2] - In 2024, the company's performance is expected to grow by 147.79% year-on-year. The projected revenue is 29.763 billion yuan, a year-on-year increase of 17.37%; net profit attributable to shareholders is 2.029 billion yuan, a year-on-year increase of 147.79%; and the net profit after deducting non-recurring items is 1.962 billion yuan, a year-on-year increase of 126.90%. For Q4 2024, revenue is expected to be 8.184 billion yuan, a year-on-year increase of 10.36% and a quarter-on-quarter increase of 8.57%; net profit attributable to shareholders is projected at 454 million yuan, a year-on-year increase of 45.50% and a quarter-on-quarter increase of 12.46% [2] - In 2024, revenue growth for various product categories is projected as follows: new chemical materials +26.83%, basic chemical products -7.41%, fertilizers +17.85%, and other products +21.84%. Gross profit margins are expected to change as follows: +1.36 percentage points, +2.68 percentage points, -1.41 percentage points, and +2.73 percentage points respectively [2] Performance Resilience - In Q1 2025, the company demonstrated resilience with revenue of 7.290 billion yuan, a year-on-year increase of 7.96% but a quarter-on-quarter decrease of 10.92%. Net profit attributable to shareholders was 413 million yuan, a year-on-year decrease of 27.30% and a quarter-on-quarter decrease of 9.04%. The net profit after deducting non-recurring items was 384 million yuan, a year-on-year decrease of 33.81% and a quarter-on-quarter decrease of 2.40%. The primary reason for the decline was the drop in prices of some chemical products, which fell more than the decrease in raw material procurement prices [3] - The company is steadily advancing its capacity construction, with refined management and energy-saving measures continuously enhancing operations. In 2024, production facilities are expected to operate safely and stably, with successful full-load operation of the caprolactam and nylon 6 phase I project, smooth integration of the silicone project, and orderly progress of the ethylene downstream integration project and 150,000 tons of propionic acid project [3] - The equipment manufacturing business is deeply integrating resources and promoting market-oriented operations of the Luxi Engineering Company, transitioning from serving Luxi to serving Sinochem. The company is expanding exports of new energy equipment and promoting capacity expansion and efficiency improvement [3] - The main raw materials for the company's chemical products include coal, propylene, pure benzene, and methanol. The company focuses on stable cooperation with large state-owned producers to secure channels and strive for price advantages, while also leveraging the proximity of local refining enterprises for cost-effective procurement [3]

Investment Rating - The industry investment rating for basic chemicals and oil & gas is maintained at "Overweight" [6] Core Viewpoints - The industry is experiencing a bottoming phase in profitability for bulk chemicals in 2024, with signs of recovery in downstream demand beginning in Q1 2025 [2][19] - The oil price has been under pressure due to geopolitical tensions and OPEC+ production cuts, leading to a decline in profitability across the oil and gas value chain [10][14] - The overall revenue for the basic chemicals and oil & gas sector in 2024 was 1,031.71 billion, with a net profit of 49.85 billion, reflecting a year-on-year decline of 1% and 0.8% respectively [12][18] Summary by Sections 2024 Annual Overview - The oil and gas sector remains relatively strong, while bulk cyclical products are facing profitability challenges [3][14] - The chemical industry is waiting for a supply-demand turning point, with 21 out of 35 sub-industries showing positive performance in A-shares [14][16] Q1 2025 Performance - In Q1 2025, the oil price decline has led to a decrease in profitability for the oil and gas sector, while downstream products are showing initial signs of recovery [19][20] - The revenue for Q1 2025 was 25,157 billion, with a net profit of 1,426 billion, indicating a year-on-year decline of 4% and 3% respectively, but a quarter-on-quarter increase of 2% and 78% [12][23] Industry Outlook - The second half of 2025 is expected to see an upward trend, driven by improved domestic and external demand, as well as capital expenditure recovery [5][10] - Recommended stocks include Meihua Biological, Xinghuo Technology, and others, which are expected to benefit from the recovery in the chemical industry [8][5]

Group 1: Financial Performance and Market Conditions - The company reported a significant increase in costs in Q1 2025 due to changes in product volume and structure, leading to a year-on-year increase in total costs [2] - Despite a year-on-year increase in production and sales volume, the company's profit declined due to a drop in the selling prices of some chemical products, which fell more than the decrease in raw material procurement prices [2] - The company has implemented flexible production scheduling in response to market changes and product profitability levels [2] Group 2: Product and Market Strategy - The company is enhancing its product scale competitiveness and risk resistance through the production of Nylon 6 and organic silicon, despite market price fluctuations [2] - The company aims to respond to market changes by adjusting product output and structure, focusing on efficiency and cost reduction [3] - The company has a target of "outperforming the market and industry average" and is actively engaging in benchmarking improvement actions [3] Group 3: Shareholder Engagement and Corporate Governance - The company plans to implement its dividend scheme within two months after the annual shareholders' meeting on May 23, 2024 [2] - The company has publicly released its Environmental, Social, and Governance (ESG) reports for three consecutive years, detailing its management in these areas [3] - The company is committed to complying with relevant laws and regulations regarding capital operations and will disclose information accordingly [2]

Group 1 - The company is expected to achieve significant profit recovery in 2024, with a projected revenue of 29.76 billion yuan (up 17.4% year-on-year) and a net profit attributable to shareholders of 2.03 billion yuan (up 147.8% year-on-year) [1] - In Q1 2025, the company anticipates a revenue of 7.29 billion yuan (up 8.0% year-on-year, down 10.9% quarter-on-quarter) and a net profit of 410 million yuan (down 27.3% year-on-year, down 9.0% quarter-on-quarter) [1] Group 2 - The chemical new materials segment generated a revenue of 20.366 billion yuan in 2024 (accounting for 68% of total revenue, up 27% year-on-year) with a gross margin of 16% (up 1 percentage point year-on-year) [2] - The polycarbonate market is experiencing supply-demand imbalance and low prices, while the nylon 6 industry is growing rapidly but facing intense competition [2] - The company successfully launched its caprolactam and nylon 6 phase I project, and the organic silicon project was smoothly put into production [2] Group 3 - The basic chemicals segment reported a revenue of 5.795 billion yuan in 2024 (accounting for 19% of total revenue, down 7% year-on-year) with a gross margin of 17% (up 3 percentage points year-on-year) [3] - The fertilizer segment achieved a revenue of 3.065 billion yuan (accounting for 10% of total revenue, up 18% year-on-year) with a gross margin of 6% (down 1 percentage point year-on-year) [3] - The increase in fertilizer revenue was driven by new projects and improved market conditions, although profitability slightly declined [3]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company's main product prices have declined, leading to a decrease in performance for the second half of 2024 and the first quarter of 2025 [6] - In 2024, the company achieved a revenue of 29.763 billion yuan, a year-on-year increase of 17.37%, and a net profit attributable to shareholders of 2.029 billion yuan, a year-on-year increase of 148% [5] - The company is expected to face challenges in 2025 due to further price declines in key products, resulting in a downward adjustment of profit forecasts for 2025-2026 [7] Summary by Sections Financial Performance - In 2024, the company reported a revenue of 29.763 billion yuan, with a net profit of 2.029 billion yuan, reflecting a significant year-on-year growth of 148% [5] - The first quarter of 2025 saw a revenue of 7.290 billion yuan, a year-on-year increase of 7.96%, but a quarter-on-quarter decrease of 10.92% [5] Business Segments - The chemical new materials segment generated a revenue of 20.4 billion yuan in 2024, up 26.8% year-on-year, while the basic chemical products segment saw a revenue of 5.8 billion yuan, down 7.4% year-on-year [6] - The fertilizer business achieved a revenue of 3.07 billion yuan, a year-on-year increase of 17.9% [6] Price Trends - The report highlights a decline in sales prices for key products in the second half of 2024 and the first quarter of 2025, with specific declines noted for PC, PA6, and other chemicals [6] Production Capacity and Management - The company has successfully resumed production of its hydrogen peroxide facility and launched new capacity projects, including a 600,000-ton caprolactam project [7] - The production target for 2025 is set at 13.5 million tons, a 40.6% increase from 2024 [7] Profit Forecasts - The profit forecasts for 2025-2027 have been adjusted downward due to the decline in product prices, with expected net profits of 2.056 billion yuan for 2025, 2.325 billion yuan for 2026, and 2.643 billion yuan for 2027 [7]

Core Viewpoint - The company reported a revenue of 29.763 billion yuan for 2024, representing a year-on-year growth of 17.4%, with a net profit attributable to shareholders of 2.029 billion yuan, corresponding to an earnings per share of 1.06 yuan, which is a significant increase of 147.8% year-on-year [1] Financial Performance - For 2024, the company's revenue was 29.763 billion yuan, with a net profit of 2.029 billion yuan, and earnings per share of 1.06 yuan, marking a 147.8% increase year-on-year [1] - In Q4 2024, revenue reached 8.184 billion yuan, with a quarter-on-quarter growth of 10.4% and a year-on-year growth of 8.6%, while net profit was 454 million yuan, showing a quarter-on-quarter increase of 45.5% and a year-on-year increase of 12.5% [1] - For Q1 2025, revenue was 7.290 billion yuan, with a quarter-on-quarter increase of 8.0% but a year-on-year decrease of 10.9%, and net profit was 413 million yuan, reflecting a quarter-on-quarter decrease of 27.3% and a year-on-year decrease of 9.0% [1] Cost Structure - In 2024, the company's sales expenses increased by 29.5%, while management expenses decreased by 3.8%, financial expenses decreased by 36.5%, and R&D expenses increased by 3.0% [1] - The reduction in financial expenses was primarily due to a decrease in interest-bearing debt and borrowing rates [1] Product Performance - The company experienced growth in chemical and fertilizer product sales, with revenues from chemical new materials, basic chemicals, and fertilizers increasing by 26.8%, -7.4%, and 17.9% year-on-year, respectively [2] - The total sales volume for chemical manufacturing and fertilizer manufacturing reached 5.0226 million tons and 1.9001 million tons, representing year-on-year increases of 13.0% and 37.6%, respectively [2] - The increase in production capacity from the company's caprolactam and nylon-6 project contributed significantly to sales growth [2] Market Trends - Formic acid prices have been on the rise, benefiting leading companies in the sector, with average prices increasing from 2,426 yuan/ton in Q3 2024 to 3,250 yuan/ton by April 25, 2025 [3] - The company is a leading producer of formic acid with an annual capacity of 400,000 tons and a market share exceeding 50% [3] - The company has ongoing projects valued at 4.760 billion yuan, including organic silicon and downstream ethylene integration projects, which are expected to contribute to future growth [3] Profit Forecast and Valuation - Due to a decline in prices for products like dibutyl phthalate, the company's net profit forecast for 2025 has been reduced by 28% to 1.730 billion yuan [4] - The 2026 profit forecast is set at 1.972 billion yuan, with the current stock price corresponding to a P/E ratio of 12.7 for 2025 and 11.1 for 2026 [4] - The target price is maintained at 14.50 yuan, reflecting a potential upside of 26.5% based on the projected P/E ratios for 2025 and 2026 [4]

Group 1: Company Performance Overview - The company achieved an operating income of approximately 29.763 billion yuan in 2024, representing a year-on-year growth of 17.37% [1] - The net profit attributable to shareholders was about 2.029 billion yuan, with a significant year-on-year increase of 147.79% [2] - The net profit excluding non-recurring gains and losses was approximately 1.962 billion yuan, reflecting a year-on-year growth of 126.9% [2] Group 2: Q1 2025 Performance - In Q1 2025, the company reported an operating income of around 7.29 billion yuan, marking a year-on-year increase of 7.96% [2] - The net profit attributable to shareholders for Q1 2025 was approximately 413 million yuan, showing a decline of 27.3% compared to the previous year [2] - The net profit excluding non-recurring gains and losses for Q1 2025 was about 384 million yuan, which is a decrease of 33.81% year-on-year [2] Group 3: Market Conditions and Product Pricing - The chemical product prices have fluctuated recently due to changes in peer company operating rates and downstream demand [1] - The company is adapting its production and sales strategies based on market conditions to mitigate risks and seize opportunities [1] Group 4: Dividend Policy - The profit distribution plan for 2024 proposes a cash dividend of 3.50 yuan (including tax) for every 10 shares based on the total share capital at the end of 2024 [2] - The company will determine future dividend plans in accordance with regulatory requirements and its operational needs [2]